logo

Biotech Daily Dose

Share

pharma 010919 31mar20 Today's Daily Dose brings you news about Akero's big day; Immunovant's Thyroid Eye Disease trial results; Court ruling in Amarin's patent suit related to Vascepa, Savara's update on its ongoing clinical trials in light of the coronavirus crisis; Johnson & Johnson's progress in its COVID-19 vaccine program.

biotech march27 Today's Daily Dose brings you news about BioSig Technologies' foray into COVID-19 drug development, FDA approval of Bristol-Myers' multiple sclerosis drug, delay in FDA panel review of Intercept Pharma's NASH drug candidate, and positive results of VBL Therapeutics' ovarian cancer trial.

pharma 050517 26mar20 Today's Daily Dose brings you news about Immutep's breast cancer trial results, ProQR Therapeutics' near-term catalyst, Eloxx Pharma pausing patient enrolment in its cystic fibrosis trial due to COVID-19 pandemic, Jazz Pharma's regulatory catalyst and Gilead seeking to revoke the coveted status for potential COVID-19 drug.

walmartpharmacy jun04 25mar20 Today's Daily Dose brings you news about CytomX Therapeutics' collaboration with Astellas Pharma to develop cancer therapies, IMAC Holdings' launch of telehealth option in the wake of the COVID-19 pandemic, Ampio suspending patient enrollment in its phase III knee osteoarthritis trial as a result of the challenges faced due to the coronavirus outbreak, and scPharmaceuticals' upcoming catalyst.

investors march23 The end of the first quarter is just around the corner. the following biotech/pharma companies are slated to report the trial results this quarter. Will they stick to the deadline?

pharma 010919 24mar20 Today's Daily Dose brings you news about Aytu BioScience's progress in its COVID-19 diagnostic tests, Roche's myeloid leukemia trial results, Milestone Pharma's disappointing NODE-301 trial results and Hoth Therapeutics getting on the bandwagon of COVID-19 drug development.

zambiachina march19 So far, 176 countries have reported COVID-19 infections, and the number of confirmed cases worldwide is 219,357 while the death toll is 8,970.

pharma 010919 19mar20 Today's Daily Dose brings you news about the FDA rejecting Eton Pharma's Lennox-Gastaut syndrome drug, the progress in IMV's COVID-19 vaccine program, delay in IVERIC bio's dry age-related macular degeneration trial, and Vaxart's deal with Emergent BioSolutions for the development of an oral vaccine candidate for COVID-19.

pharma 050517 18mar20 Today's Daily Dose brings you news about BioNTech's deal with Pfizer for developing coronavirus vaccine, the curious case of CureVac's CEO exit, Regeneron's progress in COVID-19 vaccine development, and FDA's Emergency Use Authorization of Quidel's coronavirus test.

pharma 010919 16mar20 Today's Daily Dose brings you news about Moderna's progress in COVID-19 vaccine development, cancelation of FDA Panel meeting to review DBV Technologies' peanut allergy product, District Court ruling on Mallinckrodt's base date AMP for Acthar Gel and AcelRx Pharma's acquisition of Tetraphase Pharma, among others.

disney march13 Here are the latest updates of the COVID-19 outbreak as of Thursday, March 12, 2020.

nba march12 Here are the latest updates of the COVID-19 outbreak as of Wednesday, March 11, 2020.

nadinedorriesxijinping march11 Here are the latest updates of the COVID-19 outbreak as of Tuesday, March 10, 2020.

coronavirus march10 Here are the latest updates of the COVID-19 outbreak as of Monday, March 9, 2020.

ascendispharma march09 Ascendis Pharma A/S (ASND), a clinical-stage biopharmaceutical company focusing on endocrinology rare disease, is all set to report results from a phase II study of TransCon PTH for adult hypoparathyroidism by the end of this month. Full results from this trial are expected in the third quarter.

Follow RTT
>